FigureĀ 1.
Summary of co-occurring cytogenetic alterations and comutations. (A) Occurrence of i(7)(p10) and other cytogenetic alterations. The number of cases in which i(7)(p10) was detected in the respective entities is depicted. The color indicates the presence of other cytogenetic alterations (light gray), the detection of i(7)(p10) in a subclone only (dark gray) or the presence as sole abnormality (red). (B) Number of cases with the respective comutations among the 15 AML cases with i(7)(p10). For IDH2 the mutation site is also depicted.

Summary of co-occurring cytogenetic alterations and comutations. (A) Occurrence of i(7)(p10) and other cytogenetic alterations. The number of cases in which i(7)(p10) was detected in the respective entities is depicted. The color indicates the presence of other cytogenetic alterations (light gray), the detection of i(7)(p10) in a subclone only (dark gray) or the presence as sole abnormality (red). (B) Number of cases with the respective comutations among the 15 AML cases with i(7)(p10). For IDH2 the mutation site is also depicted.

Close Modal

or Create an Account

Close Modal
Close Modal